BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8624279)

  • 1. Blood transfusion as a risk factor for non-Hodgkin lymphoma.
    Brandt L; Brandt J; Olsson H; Anderson H; Möller T
    Br J Cancer; 1996 May; 73(9):1148-51. PubMed ID: 8624279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia.
    Cerhan JR; Wallace RB; Dick F; Kemp J; Parker AS; Zheng W; Sellers TA; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):361-8. PubMed ID: 11319177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
    Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood transfusion and non-Hodgkin lymphoma: lack of association.
    Adami J; Nyrén O; Bergström R; Ekbom A; McLaughlin JK; Högman C; Fraumeni JF; Glimelius B
    Ann Intern Med; 1997 Sep; 127(5):365-71. PubMed ID: 9273827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukaemias and non-Hodgkin's lymphomas by histological type in farming-animal breeding workers: a population case-control study based on job titles.
    Amadori D; Nanni O; Falcini F; Saragoni A; Tison V; Callea A; Scarpi E; Ricci M; Riva N; Buiatti E
    Occup Environ Med; 1995 Jun; 52(6):374-9. PubMed ID: 7627313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet radiation exposure and risk of malignant lymphomas.
    Smedby KE; Hjalgrim H; Melbye M; Torrång A; Rostgaard K; Munksgaard L; Adami J; Hansen M; Porwit-MacDonald A; Jensen BA; Roos G; Pedersen BB; Sundström C; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Feb; 97(3):199-209. PubMed ID: 15687363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphocytic leukaemias and non-Hodgkin's lymphomas by histological type in farming-animal breeding workers: a population case-control study based on a priori exposure matrices.
    Nanni O; Amadori D; Lugaresi C; Falcini F; Scarpi E; Saragoni A; Buiatti E
    Occup Environ Med; 1996 Oct; 53(10):652-7. PubMed ID: 8943828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
    Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
    J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.
    Cerhan JR; Engels EA; Cozen W; Davis S; Severson RK; Morton LM; Gridley G; Hartge P; Linet M
    Int J Cancer; 2008 Aug; 123(4):888-94. PubMed ID: 18506687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
    van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
    Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender and time differences in initial location and histological grade of non-Hodgkin's lymphomas in Southern Sweden.
    Brandt L; Brandt J; Olsson H; Anderson H; Möller T
    Acta Oncol; 2001; 40(4):479-84. PubMed ID: 11504307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium.
    't Mannetje A; De Roos AJ; Boffetta P; Vermeulen R; Benke G; Fritschi L; Brennan P; Foretova L; Maynadié M; Becker N; Nieters A; Staines A; Campagna M; Chiu B; Clavel J; de Sanjose S; Hartge P; Holly EA; Bracci P; Linet MS; Monnereau A; Orsi L; Purdue MP; Rothman N; Lan Q; Kane E; Costantini AS; Miligi L; Spinelli JJ; Zheng T; Cocco P; Kricker A
    Environ Health Perspect; 2016 Apr; 124(4):396-405. PubMed ID: 26340796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples.
    Goldin LR; Landgren O; McMaster ML; Gridley G; Hemminki K; Li X; Mellemkjaer L; Olsen JH; Linet MS
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2402-6. PubMed ID: 16214923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
    Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
    BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
    Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U
    Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin lymphoma in Romania: a single-centre experience.
    Fetica B; Achimas-Cadariu P; Pop B; Dima D; Petrov L; Perry AM; Nathwani BN; Müller-Hermelink HK; Diebold J; MacLennan KA; Fulop A; Blaga ML; Coza D; Nicula FA; Irimie A; Weisenburger DD
    Hematol Oncol; 2017 Jun; 35(2):198-205. PubMed ID: 26482423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
    Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
    Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C infection and risk of malignant lymphoma.
    Schöllkopf C; Smedby KE; Hjalgrim H; Rostgaard K; Panum I; Vinner L; Chang ET; Glimelius B; Porwit A; Sundström C; Hansen M; Adami HO; Melbye M
    Int J Cancer; 2008 Apr; 122(8):1885-90. PubMed ID: 18271005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.